{"id":4761,"date":"2017-06-20T13:43:08","date_gmt":"2017-06-20T11:43:08","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/unkategorisiert\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/"},"modified":"2022-07-04T06:53:48","modified_gmt":"2022-07-04T04:53:48","slug":"auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/","title":{"rendered":"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager"},"content":{"rendered":"<p>Aufbruchsstimmung bei der Erforschung neurodegenerativer Erkrankungen: Seit M\u00e4rz 2017 ist diese Stimmung besonders am DZNE ganz deutlich sp\u00fcrbar. Yokogawa ist auch vertreten, mit dem Cell Voyager.<\/p>\n<h1><strong>Merkel weiht einen der modernsten Forschungsbauten Europas ein<\/strong><\/h1>\n<p>&nbsp;\u201eBundeskanzlerin Angela Merkel und NRW-Wissenschaftsministerin Svenja Schulze haben heute den Bonner Neubau des <a href=\"https:\/\/www.dzne.de\/home.html\">DZNE<\/a> feierlich eingeweiht und sich \u00fcber aktuelle Forschungsprojekte informiert. Am DZNE arbeiten Wissenschaftlerinnen und Wissenschaftler fach\u00fcbergreifend an neuen Therapien gegen Alzheimer, Parkinson und andere Demenz- und Nervenerkrankungen.\u201c (Quelle: <a href=\"https:\/\/www.dzne.de\/ueber-uns\/presse\/meldungen\/2017\/pressemitteilung-nr-4.html\">Pressemeldung des DZNE<\/a>)<\/p>\n<p>Merkels Rede vor Ort: <a href=\"https:\/\/www.bundeskanzlerin.de\/Content\/DE\/Rede\/2017\/03\/2017-03-16-rede-bk-dzne.html\">Text lesen<\/a>.<\/p>\n<h1><strong>\u201eLeuchtturm der Forschung\u201c<\/strong><\/h1>\n<p>Mit diesen Worten beschreibt Merkel die Forschungsarbeit am DZNE. Eine kurze Zusammenfassung der feierlichen Einweihung des knapp 127 Millionen Euro teuren Neubaus, sowie eine Rundf\u00fchrung von Forscher Dr. Philip Denner sehen sie im nachfolgenden Video.<\/p>\n<h1><strong>Automatisierte Screening-Plattform <\/strong><\/h1>\n<p>In dem obigen Video (1:03 min \u2013 1:08 min) ist eine der vier zentralen Core Facilities des DZNE zu sehen. Mit mehr als 30 unterschiedlichen, unter Reinraumbedingungen (ISO-5) integrierten Instrumenten geh\u00f6rt diese Plattform zu den modernsten ihrer Art. Mehr Informationen dazu finden Sie <a href=\"https:\/\/www.dzne.de\/forschung\/core-facilities\/laboratory-automation-technologies\/automated-screening-platform.html\">hier<\/a>.<\/p>\n<h1><strong>Der Cell Voyager am DZNE<\/strong><\/h1>\n<p>Der <a href=\"https:\/\/www.yokogawa.com\/solutions\/products-platforms\/life-science\/high-throughput-cytological-discovery-system\/\">Cell Voyager<\/a> von Yokogawa ist ein wichtiger, <a href=\"https:\/\/www.dzne.de\/forschung\/core-facilities\/laboratory-automation-technologies\/cellvoyager-cv6000-yokogawa-inc.html\">voll integrierter Bestandteil<\/a> dieser Plattform. Als High-Content-Analysis System der ersten Generation kommt es unter anderem bei hochaufgel\u00f6sten Experimenten zur Zellkinetik&nbsp; zum Einsatz. Es ist ausgestattet mit einem Temperatur, Luftfeuchtigkeits- und Kohlenstoffdioxid Kontrollmechanismus und erm\u00f6glicht daher Langzeit\u00fcberwachungen von lebenden Zellen. Durch die ausgekl\u00fcgelte, von Yokogawa patentierte Konfokale Scanning Technologie (Microlens-enhanced dual Nipkow disk confocal scanner), die allen Yokogawa Systemen aus dem Life Science Bereich zu Grunde liegt, werden die Zellen w\u00e4hrend der Abtastung besonders schonend behandelt.<\/p>\n<p><strong>Mehr Informationen zu Yokogawas Life Science Produkten finden Sie <a href=\"https:\/\/www.yokogawa.com\/solutions\/products-platforms\/life-science\/\">hier<\/a>. <\/strong><\/p>\n<p><strong>Anregungen oder Kommentare? Fragen oder Kritik? Dann schreiben Sie uns.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bundeskanzlerin Angela Merkel und NRW-Wissenschaftsministerin Svenja Schulze haben heute den Bonner Neubau des DZNE feierlich eingeweiht und sich \u00fcber aktuelle Forschungsprojekte informiert. <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/\"> <span class=\"screen-reader-text\">Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager<\/span> Weiterlesen &raquo;<\/a><\/p>\n","protected":false},"author":31,"featured_media":4762,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[1],"tags":[1073,1074,1075,1076,10,1077,1078,1079],"coauthors":[80,81],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager\" \/>\n<meta property=\"og:description\" content=\"Bundeskanzlerin Angela Merkel und NRW-Wissenschaftsministerin Svenja Schulze haben heute den Bonner Neubau des DZNE feierlich eingeweiht und sich \u00fcber aktuelle Forschungsprojekte informiert.  Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager Weiterlesen &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-20T11:43:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-04T04:53:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1154\" \/>\n\t<meta property=\"og:image:height\" content=\"645\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Niklas Frielingsdorf\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/\"},\"author\":{\"name\":\"Niklas Frielingsdorf\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f\"},\"headline\":\"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager\",\"datePublished\":\"2017-06-20T11:43:08+00:00\",\"dateModified\":\"2022-07-04T04:53:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/\"},\"wordCount\":293,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\"},\"keywords\":[\"Cell Voyager\",\"Forschung\",\"High-Content-Analysis System\",\"Life\",\"life science\",\"Screening\",\"Zelle\",\"Zellkinetik\"],\"articleSection\":[\"Unkategorisiert\"],\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/\",\"name\":\"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website\"},\"datePublished\":\"2017-06-20T11:43:08+00:00\",\"dateModified\":\"2022-07-04T04:53:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Just another blogs.yokogawa.com Sites site\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f\",\"name\":\"Niklas Frielingsdorf\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/image\/26bfbff9ac7a54d6fe4079add1304bdc\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g\",\"caption\":\"Niklas Frielingsdorf\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/niklas-frielingsdorf\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/","og_locale":"de_DE","og_type":"article","og_title":"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager","og_description":"Bundeskanzlerin Angela Merkel und NRW-Wissenschaftsministerin Svenja Schulze haben heute den Bonner Neubau des DZNE feierlich eingeweiht und sich \u00fcber aktuelle Forschungsprojekte informiert.  Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager Weiterlesen &raquo;","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2017-06-20T11:43:08+00:00","article_modified_time":"2022-07-04T04:53:48+00:00","og_image":[{"width":1154,"height":645,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2.jpg","type":"image\/jpeg"}],"author":"Niklas Frielingsdorf","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/"},"author":{"name":"Niklas Frielingsdorf","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f"},"headline":"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager","datePublished":"2017-06-20T11:43:08+00:00","dateModified":"2022-07-04T04:53:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/"},"wordCount":293,"commentCount":1,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"keywords":["Cell Voyager","Forschung","High-Content-Analysis System","Life","life science","Screening","Zelle","Zellkinetik"],"articleSection":["Unkategorisiert"],"inLanguage":"de-DE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/","name":"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website"},"datePublished":"2017-06-20T11:43:08+00:00","dateModified":"2022-07-04T04:53:48+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/auch-fuer-merkel-neu-innovatives-screening-mit-dem-cell-voyager\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/"},{"@type":"ListItem","position":2,"name":"Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","name":"Chemical Pharma Blog","description":"Just another blogs.yokogawa.com Sites site","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/f29c6dea0d8cefb06eba3da6979c681f","name":"Niklas Frielingsdorf","image":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/image\/26bfbff9ac7a54d6fe4079add1304bdc","url":"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e31ded97b5d09566514531c6356737ce?s=96&d=mm&r=g","caption":"Niklas Frielingsdorf"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/niklas-frielingsdorf\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2.jpg",1154,645,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2-300x168.jpg",300,168,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2-768x429.jpg",768,429,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2-1024x572.jpg",1024,572,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2.jpg",1154,645,false],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2.jpg",1154,645,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Screenshot_YouTube_Video_2-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Niklas Frielingsdorf","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/niklas-frielingsdorf\/"},"uagb_comment_info":1,"uagb_excerpt":"Bundeskanzlerin Angela Merkel und NRW-Wissenschaftsministerin Svenja Schulze haben heute den Bonner Neubau des DZNE feierlich eingeweiht und sich \u00fcber aktuelle Forschungsprojekte informiert. Auch f\u00fcr Merkel neu: Innovatives Screening mit dem Cell Voyager Weiterlesen &raquo;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/4761"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/comments?post=4761"}],"version-history":[{"count":2,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/4761\/revisions"}],"predecessor-version":[{"id":11332,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/4761\/revisions\/11332"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media\/4762"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media?parent=4761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/categories?post=4761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/tags?post=4761"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/coauthors?post=4761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}